Grundy S M, Cleeman J I, Rifkind B M, Kuller L H
National Cholesterol Education Program, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-2480, USA.
Arch Intern Med. 1999;159(15):1670-8. doi: 10.1001/archinte.159.15.1670.
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
